Home › Funds › Weaver C. Barksdale & Associates, Inc. › ELV
Weaver C. Barksdale & Associates, Inc. position in ELV
ELEVANCE HEALTH INC FORMERLY · Health Care
Weaver C. Barksdale & Associates, Inc. reported holding 5,252 shares of ELV (ELEVANCE HEALTH INC FORMERLY) in its Q3 2026 13F filing — a position valued at US$2.0M, representing 1.87% of its reported portfolio and ranking #20 among its reported holdings. Weaver C. Barksdale & Associates, Inc. has disclosed ELV holdings in 8 of the last 8 reported quarters, going back to Q4 2024.
Last updated: 2026-11-13 · Source: SEC EDGAR Form 13F-HR
How Weaver C. Barksdale & Associates, Inc.'s ELV position evolved
Weaver C. Barksdale & Associates, Inc. first disclosed a stake in ELV in Q4 2024 at 4,803 shares (US$1.8M). The position peaked in Q2 2026 at 5,451 shares, worth US$2.1M. Across 8 filings, Weaver C. Barksdale & Associates, Inc. increased the stake 2 time(s), trimmed it 4 time(s) and left it unchanged 1 time(s). The most recent filing (Q3 2026) shows 5,252 shares valued at US$2.0M — a reduction of -199 shares quarter over quarter..
Quarter by quarter
| Quarter | Shares | Value | Change |
|---|---|---|---|
| Q4 2024 | 4.80K | $1.77M | New |
| Q1 2025 | 4.69K | $2.04M | Reduce |
| Q2 2025 | 4.65K | $1.81M | Reduce |
| Q3 2025 | 4.38K | $1.41M | Reduce |
| Q4 2025 | 5.13K | $1.80M | Add |
| Q1 2026 | 5.47K | $1.60M | Add |
| Q2 2026 | 5.45K | $2.11M | Hold |
| Q3 2026 | 5.25K | $2.04M | Reduce |
Dots on the line are colored by change type; missing quarters mean no position was reported.
About ELV and 13F data
ELV (ELEVANCE HEALTH INC FORMERLY) is a Health Care company. 23 other funds we track also report a position in ELV — the largest reported positions include Wellington Management Group (US$3.56B), WELLINGTON MANAGEMENT GROUP LLP (US$3.56B), Sanders Capital, LLC (US$2.27B). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.
Other funds holding ELV
- Wellington Management Group 9.21M sh · $3.56B · Q2 2026
- WELLINGTON MANAGEMENT GROUP LLP 9.21M sh · $3.56B · Q2 2026
- Sanders Capital, LLC 5.83M sh · $2.27B · Q3 2026
- Harris Associates (Oakmark) 4.92M sh · $1.90B · Q2 2026
- HARRIS ASSOCIATES L P 4.92M sh · $1.90B · Q2 2026
- First Eagle Investment Management 4.20M sh · $1.63B · Q3 2026
- Artisan Partners Limited Partnership 3.76M sh · $1.46B · Q3 2026
More on Weaver C. Barksdale & Associates, Inc.
FAQ
How long has Weaver C. Barksdale & Associates, Inc. held ELV?
Weaver C. Barksdale & Associates, Inc. has disclosed ELV holdings in 8 of the last 8 reported quarters, going back to Q4 2024.
What is Weaver C. Barksdale & Associates, Inc.'s current position in ELV?
As of Q3 2026, Weaver C. Barksdale & Associates, Inc. holds 5.25K shares of ELV (ELEVANCE HEALTH INC FORMERLY), valued at $2.04M, representing 1.87% of its reported portfolio and ranking #20.
Has Weaver C. Barksdale & Associates, Inc. been buying or selling ELV?
In the latest 13F filing (Q3 2026), Weaver C. Barksdale & Associates, Inc. reduced its position in ELV. The position peaked in Q2 2026 at 5.45K shares.
Which other funds hold ELV?
Other major institutional holders of ELV include Wellington Management Group, WELLINGTON MANAGEMENT GROUP LLP, Sanders Capital, LLC, among 23 funds with disclosed positions.
Where does this data come from?
All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.